BioSpace News Archive

Edwards brings 20 years of global pharmacy and health care operations experience to Orlando-based specialty and home delivery pharmacy

HealthSnap, a leading digital and lifestyle health platform, and StrongPath™, a startup dedicated to addressing sarcopenia and other chronic diseases largely caused by inactivity, poor diet and other unhealthy behaviors, today announced a strategic partnership to leverage HealthSnap’s wellness and lifestyle data analytics platform

DiscGenics, Inc., today announced that it has received the go-ahead from an independent data safety monitoring committee (DSMC) to enroll the final 24 patients in its first-in-human U.S. clinical study of IDCT, an allogeneic, injectable disc cell therapy for mild to moderate degenerative disc disease (DDD).

ConvergeHEALTH by Deloitte today announced the launch of a robust platform for the health care ecosystem that supports two critically important patient journeys

Effective Hemostasis Achieved in 82% of Evaluable Patients with Acute Gastrointestinal Bleeding

MPSC’s continued focus on transparency in its quality performance measures empowers patients with the information they need to make well-informed decisions regarding their healthcare treatment options.

Positive findings on clinical endpoints for Budesonide Oral Suspension (BOS) presented during ACG 2019 Presidential Plenary Session

Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking about the future of digital therapeutics at two conferences this week, HLTH and CNS Summit. Andy Molnar, Vice President of Commercialization at Cognoa will also speak at HLTH about reimbursement strategies for digital therapeutics.

Based on these positive results, Lilly plans to submit for U.S. regulatory approval for pediatric patients with moderate to severe plaque psoriasis.

The Company has been allocated a Main Floor Booth – 50 Sq. Ft (# 4507)